Regional and lobular heterogeneity of human pancreas morphology and function in type 1 diabetes pathogenesis
1型糖尿病发病机制中人胰腺形态和功能的区域和小叶异质性
基本信息
- 批准号:10617206
- 负责人:
- 金额:$ 40.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-24 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAcinar CellAcinus organ componentAddressAffectAgeAmylasesAreaAtrophicAutoantibodiesAutoimmunityBeta CellBiological AssayBlood VesselsBody Weight decreasedBody mass indexC-PeptideCell CommunicationCell physiologyCellsCellular biologyCessation of lifeCharacteristicsDataDevelopmentDiabetes MellitusDiabetes preventionDigestionDiseaseDisparateDisparityElementsEndocrineEnvironmentEnzymesEventExocrine pancreasExtracellular MatrixFunctional disorderGene ExpressionGlucagonHeadHealthHeterogeneityHistologicHormonesHumanImmuneIn SituIndividualInfiltrationInflammatory ResponseInsulinInsulin-Dependent Diabetes MellitusInvestigationIslet CellIslets of LangerhansKnowledgeLipaseLobularLobuleLocationMeasuresMechanicsMediatingModificationMolecularMorphologyMusNeuronsOrganOrgan DonorOrgan WeightOutputPancreasPathogenesisPathogenicityPathologicPatternPersonsPhysiologyPositioning AttributePredispositionProceduresProcessRegulationResistanceResourcesRoleSerumSignal TransductionSliceSortingStimulusTailTechniquesTechnologyTestingTissue DonorsTissue Slice TechnologyTissuesTrypsinogenVariantVascularizationWeightautoimmune pathogenesisblood glucose regulationcellular imagingdensitydiabetes pathogenesisexperienceimaging studyimmune cell infiltrateimprovedinsulitisisletlymphatic vesselmorphometrynerve supplynew therapeutic targetnon-diabeticnovelperipheral bloodpreservationpreventprogramsregional differenceresponsesextraittwo-dimensional
项目摘要
Through programs such as the Network for Pancreatic Organ donors with Diabetes (nPOD), highly valuable
tissues from persons with various stages and durations of type 1 diabetes (T1D) are now available. As a result,
our collective knowledge of the pathogenic events underlying T1D development has improved substantially.
However, studies simultaneously assessing functional and morphological traits of the human pancreas have not
been performed, limiting our understanding of the processes governing organ physiology in health versus
pathophysiology in T1D. Despite being in important research resource, investigations of isolated islets are
confounded by the isolation procedure, which induces an inflammatory response, morphological modifications,
and altered gene expression. Furthermore, the isolation procedure relies on the structural integrity of the islets
to withstand the enzymatic and mechanical sorting process. Most importantly, separation of islets from their
surrounding tissue removes any influence and information regarding the local adjacent elements, which could
be of importance, especially in pathological settings. We believe the characterization of islets as well as exocrine
tissues (function, regulation, and cellular interactions) and their roles in the pathogenesis of T1D would be
improved through studies of viable human pancreatic tissue containing intact islets and acini. We propose to
utilize the extremely novel pancreas tissue slice technology to substantially expand our knowledge of endocrine
and exocrine function and their interaction in normal (i.e., control) and T1D pancreas tissues obtained through
the nPOD program. This technology, originally established by Dr. Speier (mPD/PI, HMGU), produces “slices” of
fresh pancreatic tissue with minimal mechanical damage and without enzymatic digestion; enabling in situ
investigations of islet cell biology in a relatively unperturbed tissue setting. Following functional stimulation
assays for endocrine (insulin and glucagon) and exocrine secretion (amylase, lipase, trypsinogen) as well as
dynamic imaging studies of cellular signaling (Ca2+ flux), slices will be fixed and analyzed by 3D morphometry.
Amongst the many questions that will be addressed, we seek to improve our understanding on the functional
implications of the lobular and regional (i.e., head, body or tail) heterogeneous pancreatic morphology, including
islet density, size and cellular composition, exocrine enzyme expression and distribution, as well as vascular and
neuronal density. Furthermore, we aim to address its role in the distinct lobular and regional pathological
progression of T1D (i.e., insulitis, β-cell dysfunction and destruction, loss of acinar cell/organ mass). Thus, we
pose to test the hypothesis that the disparate organ weight loss as well as the lobular heterogeneity of insulitis
and β-cell destruction within the human T1D pancreas is the result of inter-regional and intra-lobular
differences in endocrine and exocrine pancreas morphology and function. Our objective is to correlate islet
and exocrine physiology and pathophysiology to their location within the pancreas and to cellular characteristics
of the surrounding microenvironment; efforts that should impact attempts at T1D prevention/reversal.
通过诸如糖尿病胰腺器官捐献者网络 (nPOD) 等计划,非常有价值
因此,来自不同阶段和持续时间的 1 型糖尿病 (T1D) 患者的组织现已可用。
我们对 T1D 发展背后的致病事件的集体了解已大大提高。
然而,同时评估人类胰腺功能和形态特征的研究尚未
已进行,限制了我们对健康器官生理学控制过程的理解
T1D 的病理生理学 尽管正在进行重要的研究资源调查,但孤立的胰岛仍然存在。
被隔离程序所困扰,该程序会引起炎症反应、形态改变,
此外,分离过程依赖于胰岛的结构完整性。
承受酶促和机械分选过程,最重要的是,将胰岛与其分离。
周围组织消除了有关局部相邻元素的任何影响和信息,这可能
很重要,特别是在病理环境中。我们相信胰岛和外分泌的特征。
组织(功能、调节和细胞相互作用)及其在 T1D 发病机制中的作用将是
我们建议通过对含有完整胰岛和腺泡的活人胰腺组织的研究来改进。
利用极其新颖的胰腺组织切片技术大大扩展我们对内分泌的知识
正常(即对照)和 T1D 胰腺组织中的外分泌功能及其相互作用
nPOD 程序最初由 Speier 博士(mPD/PI,HMGU)建立,可生产“切片”
新鲜的胰腺组织,机械损伤最小,无需酶消化;
在功能刺激后相对不受干扰的组织环境中对胰岛细胞生物学进行研究。
内分泌(胰岛素和胰高血糖素)和外分泌(淀粉酶、脂肪酶、胰蛋白酶原)以及
细胞信号传导(Ca2+通量)的动态成像研究,切片将被固定并通过 3D 形态测量法进行分析。
在将要解决的许多问题中,我们寻求提高对功能性的理解
小叶和区域(即头部、身体或尾部)异质胰腺形态的影响,包括
胰岛密度、大小和细胞组成、外分泌酶表达和分布,以及血管和
此外,我们的目标是解决其在独特的小叶和区域病理中的作用。
T1D 的进展(即胰岛炎、β 细胞功能障碍和破坏、腺泡细胞/器官质量损失)。
检验以下假设:不同的器官重量减轻以及胰岛炎的小叶异质性
人类 T1D 胰腺内的 β 细胞破坏是区域间和小叶内的结果
内分泌和外分泌胰腺形态和功能的差异我们的目标是关联胰岛。
外分泌生理学和病理生理学及其在胰腺内的位置和细胞特征
周围微环境的影响;影响 T1D 预防/逆转尝试的努力。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
ACE2 chromogenic immunostaining protocol optimized for formalin-fixed paraffin-embedded human tissue sections.
针对福尔马林固定石蜡包埋的人体组织切片优化的 ACE2 显色免疫染色方案。
- DOI:
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Jorgensen, Marda;Joseph, Paul;Posgai, Amanda L;Vander Heide, Richard S;Kusmartseva, Irina;Atkinson, Mark A
- 通讯作者:Atkinson, Mark A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK A. ATKINSON其他文献
MARK A. ATKINSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK A. ATKINSON', 18)}}的其他基金
Biorepository and Coordinating Center for Studies on Cardiovascular Complications of Human Type 1 Diabetes
人类1型糖尿病心血管并发症研究生物储存库和协调中心
- 批准号:
10512888 - 财政年份:2022
- 资助金额:
$ 40.7万 - 项目类别:
Biorepository and Coordinating Center for Studies on Cardiovascular Complications of Human Type 1 Diabetes
人类1型糖尿病心血管并发症研究生物储存库和协调中心
- 批准号:
10672443 - 财政年份:2022
- 资助金额:
$ 40.7万 - 项目类别:
Biorepository and Coordinating Center for Studies on Cardiovascular Complications of Human Type 1 Diabetes
人类1型糖尿病心血管并发症研究生物储存库和协调中心
- 批准号:
10879240 - 财政年份:2022
- 资助金额:
$ 40.7万 - 项目类别:
Co-registration of Cell Organization, Phenotype and Function in the Human Pancreas During Type 1 Diabetes
1 型糖尿病期间人类胰腺细胞组织、表型和功能的共同注册
- 批准号:
10490416 - 财政年份:2021
- 资助金额:
$ 40.7万 - 项目类别:
Co-registration of Cell Organization, Phenotype and Function in the Human Pancreas During Type 1 Diabetes
1 型糖尿病期间人类胰腺细胞组织、表型和功能的共同注册
- 批准号:
10673726 - 财政年份:2021
- 资助金额:
$ 40.7万 - 项目类别:
Co-registration of Cell Organization, Phenotype and Function in the Human Pancreas During Type 1 Diabetes
1 型糖尿病期间人类胰腺细胞组织、表型和功能的共同注册
- 批准号:
10343979 - 财政年份:2021
- 资助金额:
$ 40.7万 - 项目类别:
Regional and lobular heterogeneity of human pancreas morphology and function in type 1 diabetes pathogenesis
1型糖尿病发病机制中人胰腺形态和功能的区域和小叶异质性
- 批准号:
10400943 - 财政年份:2020
- 资助金额:
$ 40.7万 - 项目类别:
相似国自然基金
BCL2L1/FUNDC1介导的线粒体自噬失衡调控腺泡细胞铁死亡在急性胰腺炎发病中的作用及机制研究
- 批准号:82370651
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
清胰颗粒调控重症急性胰腺炎腺泡细胞脂质代谢重塑机制诠释“通腑泻浊”新内涵
- 批准号:82374248
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
衣康酸介导KDM3A/H3K9/PARP9轴调控DNA损伤修复在急性胰腺炎腺泡细胞坏死中的作用和机制研究
- 批准号:82370653
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
线粒体丙酮酸载体调控腺泡细胞糖代谢和钙超载减轻急性胰腺炎的功能与机制研究
- 批准号:82270672
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
内质网应激通过sXBP1/HIF-1α/mTOR轴调控腺泡细胞缺陷性自噬在急性胰腺炎发病中的作用及其机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
R21 MPI microRNA directed therapy for treating early stage pancreatic cancer
R21 MPI microRNA 定向疗法治疗早期胰腺癌
- 批准号:
10577609 - 财政年份:2023
- 资助金额:
$ 40.7万 - 项目类别:
Determining Sox10-mediated plasticity in irradiated salivary gland cells
确定受辐射唾液腺细胞中 Sox10 介导的可塑性
- 批准号:
10606665 - 财政年份:2023
- 资助金额:
$ 40.7万 - 项目类别:
Bottom-Up Assembly of Functional Salivary Gland Tissues
功能性唾液腺组织的自下而上组装
- 批准号:
10400243 - 财政年份:2021
- 资助金额:
$ 40.7万 - 项目类别:
Epithelial-immune cell crosstalk during injury and recovery in acute pancreatitis
急性胰腺炎损伤和恢复过程中上皮-免疫细胞的串扰
- 批准号:
10543109 - 财政年份:2021
- 资助金额:
$ 40.7万 - 项目类别:
Dissecting mechanisms of tumor initiation via immunomodulation
通过免疫调节剖析肿瘤发生机制
- 批准号:
10166185 - 财政年份:2021
- 资助金额:
$ 40.7万 - 项目类别: